Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
69.57
2.63 (3.93%)
At close: Sep 04, 2025, 3:59 PM
70.09
0.75%
Pre-market: Sep 05, 2025, 09:11 AM EDT
3.93% (1D)
| Bid | 65.34 |
| Market Cap | 3.7B |
| Revenue (ttm) | 32.66M |
| Net Income (ttm) | -181.08M |
| EPS (ttm) | -4.22 |
| PE Ratio (ttm) | -16.49 |
| Forward PE | 22.24 |
| Analyst | Buy |
| Ask | 70.1 |
| Volume | 1,090,066 |
| Avg. Volume (20D) | 1,379,524 |
| Open | 67.42 |
| Previous Close | 66.94 |
| Day's Range | 66.36 - 70.11 |
| 52-Week Range | 41.50 - 90.32 |
| Beta | -2.56 |
About SLNO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLNO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLNO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Soleno Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-9.23%
Soleno Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
3 months ago
+2.14%
Soleno Therapeutics shares are trading higher after Guggenheim and Baird raised their respective price targets on the stock.
4 weeks ago · seekingalpha.com
Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call TranscriptSoleno Therapeutics, Inc. (NASDAQ:SLNO ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Anish Bhatnagar - Chairman, President, CEO & COO James H. MacKaness - CFO & Com...
4 weeks ago · fool.com
Soleno (SLNO) Q2 Revenue Jumps 30%Soleno (SLNO) Q2 Revenue Jumps 30%
